Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: Japan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20091
20101
20111
20164
20174
20183
20191
20202
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Bristol-Myers Squibb3
Hoffmann-La Roche3
AstraZeneca2
Amgen1
Daiichi Sankyo Co., Ltd.1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Haruhiko Fukuda1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma24
Carcinoma, Non-Small-Cell Lung5
Neoplasms5
Ovarian Neoplasms4
Stomach Neoplasms4
Carcinoma, Hepatocellular3
Carcinoma, Merkel Cell3
Lung Neoplasms3
Mesothelioma3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.